161715-28-2Relevant articles and documents
Tebipenem pivoxil intermediate and synthesis method and application thereof
-
Paragraph 0059-0064, (2020/02/14)
The invention belongs to the technical field of medicine, and particularly relates to a tebipenem pivoxil intermediate and a synthesis method and application thereof. The synthesis method comprises the following steps: with ethylamine and chloroacetamide
Syntheses and pharmacokinetic studies of prodrug esters for the development of oral carbapenem, L-084
Isoda, Takeshi,Ushirogochi, Hideki,Satoh, Koichi,Takasaki, Tsuyoshi,Yamamura, Itsuki,Sato, Chisato,Mihira, Ado,Abe, Takao,Tamai, Satoshi,Yamamoto, Shigeki,Kumagai, Toshio,Nagao, Yoshimitsu
, p. 241 - 247 (2007/10/03)
We discovered an orally active carbapenem, L-084, through pharmacokinetic studies on various prodrug esters of (1R,5S,6S)-6-[(R)-1-hydroxyethyl]-1-methyl- 2-[1-(1,3-thiazolin-2-yl)azetidin-3-yl]thio-1-carbapen-2-em-3-carboxylic acid (LJC11,036). L-084 showed a strong antimicrobial activity against Gram-positive and Gram-negative bacteria and exhibited the highest intestinal absorption among synthesized prodrugs of LJC11,036. Japan Antibiotics Research Association.